Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Intellia Therapeutics Inc buy William Blair

Start price
€35.09
25.03.23 / 50%
Target price
-
25.03.24
Performance (%)
-29.81%
End price
€24.63
26.03.24
Summary
This prediction ended on 26.03.24 with a price of €24.63. The prediction for Intellia Therapeutics Inc disappointed with a performance of -29.81%. William_Blair has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Intellia Therapeutics Inc 13.026% 13.026% -37.275%
iShares Core DAX® -0.922% -1.993% 13.399%
iShares Nasdaq 100 0.371% -0.868% 41.541%
iShares Nikkei 225® 2.224% -5.187% 20.497%
iShares S&P 500 -0.026% -0.918% 30.410%

Comments by William_Blair for this prediction

In the thread Intellia Therapeutics Inc diskutieren

Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its "outperform" rating re-affirmed by analysts at William Blair.
Ratings data for NTLA provided by MarketBeat

In the thread Trading Intellia Therapeutics Inc
Prediction Buy
Perf. (%) -29.81%
Target price
Change
Ends at 25.03.24

Die von William_Blair gewählte maximale Laufzeit wurde überschritten